Yezi Zou

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Author Correction: Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

Author Correction: Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

Journal: Nature cancer
Published: July 16, 2026

Correction: The KLF16/MYC feedback loop is a therapeutic target in bladder cancer.

Correction: The KLF16/MYC feedback loop is a therapeutic target in bladder cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 27, 2026

ASB7 promotes osteosarcoma lung metastasis through ubiquitin-mediated degradation of ATF2.

ASB7 promotes osteosarcoma lung metastasis through ubiquitin-mediated degradation of ATF2.

Journal: Cell discovery
Published: October 13, 2025

TMEM199 promotes PD-L1 expression and tumor immune evasion by activating the recycling of IFNGR1/2.

TMEM199 promotes PD-L1 expression and tumor immune evasion by activating the recycling of IFNGR1/2.

Journal: Cancer letters
Published: June 13, 2025

ASB7 is a negative regulator of H3K9me3 homeostasis.

ASB7 is a negative regulator of H3K9me3 homeostasis.

Journal: Science (New York, N.Y.)
Published: May 29, 2025

SUMOylation of SETD8 Promotes Tumor Growth by Methylating and Stabilizing MYC in Bladder Cancer.

SUMOylation of SETD8 Promotes Tumor Growth by Methylating and Stabilizing MYC in Bladder Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 27, 2025

The KLF16/MYC feedback loop is a therapeutic target in bladder cancer.

The KLF16/MYC feedback loop is a therapeutic target in bladder cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 14, 2024

Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer.

Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 23, 2023

Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

Journal: Nature cancer
Published: April 26, 2022

SUMOylation stabilizes hSSB1 and enhances the recruitment of NBS1 to DNA damage sites.

SUMOylation stabilizes hSSB1 and enhances the recruitment of NBS1 to DNA damage sites.

Journal: Signal transduction and targeted therapy
Published: December 04, 2019

Paeonol Ameliorates Diabetic Renal Fibrosis Through Promoting the Activation of the Nrf2/ARE Pathway via Up-Regulating Sirt1.

Paeonol Ameliorates Diabetic Renal Fibrosis Through Promoting the Activation of the Nrf2/ARE Pathway via Up-Regulating Sirt1.

Journal: Frontiers in pharmacology
Published: February 18, 2018

Progestin and AdipoQ Receptor 3 Upregulates Fibronectin and Intercellular Adhesion Molecule-1 in Glomerular Mesangial Cells via Activating NF-κB Signaling Pathway Under High Glucose Conditions.

Progestin and AdipoQ Receptor 3 Upregulates Fibronectin and Intercellular Adhesion Molecule-1 in Glomerular Mesangial Cells via Activating NF-κB Signaling Pathway Under High Glucose Conditions.

Journal: Frontiers in endocrinology
Published: November 18, 2017
Showing 1-12 of 14

Last Updated: 09/26/2026